PG

The Procter & Gamble Company at a Glance: What the Business Does The Procter & Gamble Company (PG) is a leading player in the consumer defensive sector, specializing in household and personal products. Headquartered in Cincinnati, Ohio, PG operates through five main segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. Its extensive portfolio includes well-known brands such as Head & Shoulders, Olay, Gillette, and Pampers, which are household staples for consumers worldwide. PG’s competitive advantages lie in its strong brand equity, expansive distribution network, and robust marketing strategies, allowing it to maintain a significant market position in the Household & Personal Products industry. Furthermore, the company's commitment to innovation and sustainability enhances its appeal to environmentally-conscious consumers, setting it apart from competitors. With a workforce of approximately 108,000 employees, PG continues to leverage its scale and expertise to drive growth and profitability. Breaking Down PG's Financials: Revenue, Margins & EPS In the latest financial year, Procter & Gamble reported revenue of $87.03 billion, reflecting a year-over-year increase of 3.3% from $84.28 billion. This growth trajectory has shown a consistent upward trend over the past three years, with revenues climbing from $84.04 billion in 2024 to the current figure. The company maintains strong profit margins, with a gross margin of 50.2%, operating margin of 22.7%, and a net margin of 18.4%. These margins indicate PG’s operational efficiency and pricing power within its market. Additionally, the earnings per share (EPS) stood at $6.62, marking a 1.7% increase compared to the previous year, which is a positive reflection of the company's profitability. The EBITDA of $22.91 billion further underscores PG's capacity to generate earnings from its operations, highlighting its solid financial performance. PG Balance Sheet Check: Debt, Cash & Liquidity Analyzing Procter & Gamble's balance sheet reveals a relatively strong financial position, though with some leverage. The company holds total assets of $126.52 billion against total liabilities of $72.21 billion, resulting in shareholders' equity of $54.31 billion. PG's total debt stands at $29.30 billion, balanced by cash reserves of $9.94 billion, leading to a net debt of $19.36 billion. The debt-to-equity ratio of 0.54 suggests that PG is not overly reliant on debt financing, which is a positive indicator for potential investors. However, the current ratio of 0.68 indicates a tighter liquidity position, suggesting that the company may face challenges in meeting short-term liabilities. Overall, while PG's balance sheet exhibits strength, its moderate leverage warrants attention from investors. Where Does PG's Cash Go? A Capital Allocation Review Procter & Gamble generates significant operating cash flow, reported at $19.56 billion, which provides a solid foundation for its capital allocation strategy. The company has demonstrated a strong ability to produce free cash flow, amounting to $15.15 billion, reflecting a healthy growth rate of 7.9% year-over-year. PG has utilized its cash flow for various purposes, including capital expenditures of $4.41 billion, dividends paid of $10.23 billion, and stock buybacks totaling $5.03 billion. This approach indicates a balanced allocation of capital towards returning value to shareholders while still investing in future growth. The consistent generation of free cash flow allows PG to maintain its dividend commitments, although a lack of dividend yield may deter certain income-focused investors. The company’s capital deployment strategy appears sustainable, reinforcing its long-term growth potential. PG Valuation: Expensive, Cheap, or Fairly Priced? When evaluating Procter & Gamble's valuation, several key ratios come into play. The price-to-earnings (P/E) ratio is currently at 22.09, which is relatively high for the Consumer Defensive sector, suggesting that the stock might be perceived as overvalued given its growth rates. The price-to-book (P/B) ratio stands at 6.26, while the price-to-sales (P/S) ratio is 3.91, both indicating premium valuations compared to industry averages. Meanwhile, the enterprise value to EBITDA (EV/EBITDA) ratio of 15.68 further supports the notion that PG is trading at a premium relative to its earnings potential. These valuation metrics imply that investors may have high expectations for PG's future growth. However, the current pricing could pose risks if the company fails to meet these elevated expectations in the coming years. Catalysts Ahead: PG's Growth Outlook & Analyst Estimates The growth outlook for Procter & Gamble hinges on several key factors, including market expansion opportunities and product innovation. While specific analyst estimates are not available, the company's historical revenue growth trajectory suggests a positive trend, with revenues expected to continue increasing. Key growth drivers include the rising demand for health and hygiene products, particularly post-pandemic, alongside a growing focus on sustainability and eco-friendly products. Additionally, PG's established brands and global reach position it well to capture market share across various regions. As consumer preferences evolve, the company’s ability to adapt and innovate will be critical in maintaining its competitive edge. Investors should monitor PG's performance closely as the firm navigates these opportunities. PG Investment Risks Worth Knowing About Investing in Procter & Gamble is not without its risks. The company's total debt of $29.30 billion, while manageable, could become a concern if interest rates rise or if cash flows decline, impacting its ability to service debt. Additionally, margin compression is a potential risk due to rising raw material costs and competitive price pressures, which could affect profitability. PG also faces competitive threats from both established brands and emerging companies that may disrupt its market share. Regulatory risks, particularly regarding product safety and environmental standards, could impose additional costs or operational challenges. Given its beta of 0.38, PG exhibits lower volatility compared to the broader market, yet it remains sensitive to macroeconomic conditions that could impact consumer spending. 2026 Outlook: Is The Procter & Gamble Company Stock Worth Owning? In conclusion, The Procter & Gamble Company presents a compelling investment opportunity for those seeking exposure to a stable, well-established consumer goods provider. While the company showcases strong financials, including solid revenue growth and profitability margins, its valuation ratios suggest that investors need to weigh potential growth against premium pricing. With a robust balance sheet and consistent free cash flow generation, PG is well-positioned to navigate market challenges and capitalize on growth opportunities. However, investors should remain vigilant about the risks associated with debt levels and competitive dynamics. Overall, PG stock may appeal to a diverse range of investors, from those seeking stability to those looking for growth in the consumer defensive sector. Monitoring upcoming earnings and market trends will be crucial for making informed investment decisions in the coming years.

Financial figures come from The Procter & Gamble Company's latest annual SEC filing (fiscal year 2026), so they can lag recent quarters. Prices are delayed up to 15 minutes.

About The Procter & Gamble Company

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamin

Frequently Asked Questions about PG